Medicine and Dentistry
Placenta Accreta
100%
Ovarian Cancer
97%
Cytoreductive Surgery
86%
Cervical Cancer
50%
Systematic Review
48%
Krukenberg Tumor
39%
Neoplasm
36%
Meta-Analysis
33%
Imiquimod
30%
Cervical Intraepithelial Neoplasia
28%
Hysterectomy
28%
Prospective Cohort Study
27%
Malignant Neoplasm
27%
Randomized Controlled Trial
25%
Placenta
24%
Observational Study
24%
Carcinoma in Situ
23%
Cesarean Section
20%
Quality of Life
19%
Bleeding
19%
Lymph Node
19%
Magnetic Resonance Imaging
16%
Postoperative Complication
16%
Salpingooophorectomy
16%
Diseases
16%
Electrocoagulation
16%
Ovarian Cancer Surgery
15%
Cervix
15%
Squamous Cell Carcinoma
15%
Carcinoma
15%
Carcinosarcoma
15%
Tissue Injury
15%
Overall Survival
14%
Receptor Expression
13%
Placebo
13%
Hormone Therapy
13%
Metastatic Carcinoma
13%
Uterine Cancer
13%
Biological Marker
13%
Recurrent Disease
12%
Spectrum Disorder
11%
Neoadjuvant Chemotherapy
11%
Retroperitoneal Lymph Node Dissection
10%
Pelvis
10%
Endometrium Carcinoma
10%
Odds Ratio
10%
Surgical Technique
9%
Hyperthermia
9%
Thermal Injury
9%
Estrogen Receptor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Placenta Accreta
32%
Ovary Cancer
30%
Imiquimod
30%
Uterine Cervix Carcinoma in Situ
25%
Neoplasm
24%
Chemotherapy
23%
Ovary Carcinoma
16%
Uterine Cervix Cancer
15%
Recurrent Disease
14%
Bleeding
12%
Hormone Cancer Therapy
12%
Maternal Morbidity
11%
Biological Marker
11%
Endometrium Cancer
10%
Observational Study
10%
Prospective Cohort Study
9%
Estrogen Receptor
9%
Randomized Controlled Trial
8%
Progesterone Receptor
8%
Carcinomatous Peritonitis
7%
Hyperthermia
7%
Carcinoma in Situ
7%
Retained Placenta
7%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
7%
Chemoradiation Therapy
7%
Aneuploidy
7%
Endometrium Carcinoma
7%
Hormone Receptor
7%
Disease Exacerbation
7%
Retrospective Study
7%
Hyperspectral Image
7%
Carcinosarcoma
7%
Oxytocin
7%
Mortality Rate
7%
Antenatal Corticosteroid
7%
Base
7%
Maternal Mortality
7%
Overall Survival
6%
Side Effect
5%